The Frequency of Ras Mutations in Cancer
Ian A. Prior, Fiona E. Hood, James L. Hartley
University of Liverpool Frederick National Laboratory for Cancer Research
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Ras is frequently mutated in cancer, however, there is a lack of consensus in the literature regarding the cancer mutation frequency of Ras, with quoted values varying from 10%-30%. This variability is at least in part due to the selective aggregation of data from different databases and the dominant influence of particular cancer types and particular Ras isoforms within these datasets. To provide a more definitive figure for Ras mutation frequency in cancer, we cross-referenced the data in all major publicly accessible cancer mutation databases to determine reliable mutation frequency values for each Ras isoform in all major cancer types. These percentages were then applied to current U.S. cancer incidence statistics to estimate the number of new patients each year that have Ras-mutant cancers. We find that approximately 19% of patients with cancer harbor Ras mutations, equivalent to approximately 3.4 million new cases per year worldwide. We discuss the Ras isoform and mutation-specific trends evident within the datasets that are relevant to current Ras-targeted therapies.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Protein Kinase Regulation and GTPase Signaling
Cancer Genomics and Diagnostics · Protein Tyrosine Phosphatases
参考文献 57
此处列出前 3 条
引用本文 1,119
按被引量排序,此处列出前 3 条